Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Teleflex Inc. closed 44.33% below its 52-week high of $249.91, which the company reached on September 27th.

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Teleflex (TFX – Research Report) received a Hold rating and price target from Raymond James analyst Jayson Bedford today. The company’s ...

Teleflex Incorporated (NYSE:TFX) will pursue a plan to separate into two new, independent, publicly traded companies: New, ...

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...

Teleflex (NYSE: TFX) announced today that it plans to separate its Urology, Acute Care and OEM businesses into a new publicly ...

Teleflex said on Thursday it would split into two by spinning off its business that makes devices for the urology, and acute care markets as well as its contract manufacturing unit. That would make ...

Teleflex shares tumbled to a 52-week low on Thursday after the medical-technology company posted disappointing financial guidance and unveiled plans for a nearly $800 million acquisition and a spinoff ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

Principal Financial Group Inc. reduced its stake in Teleflex Incorporated (NYSE:TFX – Free Report) by 13.1% during the fourth ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...